The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2015
Filed:
Jan. 31, 2013
Applicants:
Gerard Karsenty, New York, NY (US);
Grzegorz Sumara, New York, NY (US);
Olga Sumara, New York, NY (US);
Inventors:
Gerard Karsenty, New York, NY (US);
Grzegorz Sumara, New York, NY (US);
Olga Sumara, New York, NY (US);
Assignee:
The Trustees of Columbia University in the City of New York, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/47 (2006.01); A61K 45/06 (2006.01); A61K 31/513 (2006.01); A61K 31/505 (2006.01); C12Q 1/26 (2006.01); G01N 33/94 (2006.01);
U.S. Cl.
CPC ...
C07D 239/47 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 45/06 (2013.01); C12Q 1/26 (2013.01); G01N 33/942 (2013.01); G01N 2333/90245 (2013.01); G01N 2800/042 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention provides methods and therapeutic agents for lowering serum or plasma serotonin levels in a patient in order to prevent or treat diabetes. In preferred embodiments, the patient is known to have, or to be at risk for, diabetes and the agents are TPH1 inhibitors.